Taipei Exchange - Delayed Quote TWD

Holy Stone Healthcare Co., Ltd. (4194.TWO)

7.22
+0.01
+(0.14%)
As of 9:03:39 AM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
118,766
118,766
236,890
270,243
217,082
Cost of Revenue
85,906
85,906
137,506
146,966
115,255
Gross Profit
32,860
32,860
99,384
123,277
101,827
Operating Expense
222,669
222,669
387,674
273,246
271,638
Operating Income
-189,809
-189,809
-288,290
-149,969
-169,811
Net Non Operating Interest Income Expense
2,674
2,674
1,814
1,883
333
Pretax Income
-183,467
-183,467
-284,423
-146,436
-176,139
Tax Provision
26
26
4,947
6,507
5,169
Net Income Common Stockholders
-183,493
-183,493
-289,370
-152,943
-181,308
Diluted NI Available to Com Stockholders
-183,493
-183,493
-289,370
-152,943
-181,308
Basic EPS
-1.29
--
-2.12
-1.27
-1.65
Diluted EPS
-1.29
--
-2.12
-1.27
-1.65
Basic Average Shares
142,242.64
--
136,495.28
120,289.28
109,960.50
Diluted Average Shares
142,242.64
--
136,495.28
120,289.28
109,960.50
Total Expenses
308,575
308,575
525,180
420,212
386,893
Net Income from Continuing & Discontinued Operation
-183,493
-183,493
-289,370
-152,943
-181,308
Normalized Income
-183,481
-183,481
-289,118.80
-153,756.60
-176,786.40
Interest Income
3,311
3,311
2,514
2,507
844
Interest Expense
637
637
700
624
511
Net Interest Income
2,674
2,674
1,814
1,883
333
EBIT
-182,830
-182,830
-283,723
-145,812
-175,628
EBITDA
-170,755
-170,755
-266,415
-128,372
-157,797
Reconciled Cost of Revenue
85,906
85,906
137,506
146,966
115,255
Reconciled Depreciation
12,075
12,075
17,308
17,440
17,831
Net Income from Continuing Operation Net Minority Interest
-183,493
-183,493
-289,370
-152,943
-181,308
Total Unusual Items Excluding Goodwill
-15
-15
-314
1,017
-5,652
Total Unusual Items
-15
-15
-314
1,017
-5,652
Normalized EBITDA
-170,740
-170,740
-266,101
-129,389
-152,145
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-3
-3
-62.80
203.40
-1,130.40
12/31/2021 - 12/13/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6580.TWO TaiRx, Inc.
24.10
+0.42%
 
7607.TWO DuoGenic StemCells corporation
13.75
-4.18%
 
6848.TWO RBC Bioscience Corporation
18.20
0.00%
 
4197.TWO Visgeneer Inc.
10.45
-0.48%
 
4170.TWO VBI
12.70
-2.26%
 
6827.TWO MegaPro Biomedical Co., Ltd
9.80
+1.24%
 
4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.
13.95
0.00%
 
6617.TWO Gongwin Biopharm Holdings Co., Ltd.
109.50
0.00%
 
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.90
0.00%
 
6610.TWO TWi Biotechnology, Inc.
11.00
0.00%